Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/28/1993 | CA2089556A1 Assay for a new gaucher disease mutation |
03/27/1993 | CA2079197A1 Recombinant nda new molecules containing the codifying part of a vbeta 17 chain for the t-cells antigene receptor, preparat ion process, antibodies and drugs containing them |
03/27/1993 | CA2078906A1 Process for the specific production of ribonucleic acids |
03/27/1993 | CA2078905A1 Process for the specific amplification of nucleic acid sequences |
03/26/1993 | CA2078851A1 Treponema hyodysenteriae vaccine |
03/25/1993 | CA2079027A1 Increased expression of low molecular weight recombinant polypeptides |
03/25/1993 | CA2078721A1 Process for preparing human coagulation factor viii protein complex |
03/24/1993 | EP0533469A1 Expression vector and silkworm larvae transformant containing the same |
03/24/1993 | EP0533350A1 DNA encoding precursor interleukin 1B converting enzyme |
03/24/1993 | EP0533263A2 A multivalent hepatitis B virus vaccine |
03/24/1993 | EP0533226A2 Novel chromophore containing compounds |
03/24/1993 | EP0533216A1 Process for the preparation of L-tertiairy-leucin by transamination |
03/24/1993 | EP0533199A2 Application to a chimeric antibody directed against ganglioside GD3 |
03/24/1993 | EP0533153A2 Pichia pastoris linear plasmids and DNA fragments thereof |
03/24/1993 | EP0533010A2 Pinosylvin-Synthase-Gene |
03/24/1993 | EP0533006A1 Chimaeric interleukin 5-receptor/immunoglobulin polypeptides |
03/24/1993 | EP0532979A2 Peptides for the preparation of means for diagnosis and therapy of systemic lupus |
03/24/1993 | EP0532673A1 Immunoassays for anti-hiv-1 antibodies |
03/24/1993 | EP0532655A1 CLONING AND EXPRESSING VARIOUS RESTRICTION ENDONUCLEASES AND MODIFICATION METHYLASES FROM $i(NEISSERIA) |
03/24/1993 | EP0532650A1 Method of inducing plant defense mechanisms. |
03/24/1993 | EP0532587A1 Methods for trans-destabilization of specific proteins in vivo |
03/24/1993 | EP0532533A1 Novel enzyme preparations and methods for their production. |
03/24/1993 | EP0532525A1 New protein-polycation conjugates. |
03/24/1993 | EP0510085A4 Dna-dependent rna polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays |
03/24/1993 | EP0345315B1 Ps2 protein derivative |
03/24/1993 | EP0312540B1 Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins |
03/24/1993 | EP0211894B1 Fsh |
03/24/1993 | EP0180603B1 Rotavirus |
03/24/1993 | EP0134799B1 Expression of plasmodium falciparum polypeptides from cloned cdna |
03/24/1993 | CN1070227A DNA sequences encoding gelonin polypeptide |
03/24/1993 | CA2078801A1 Enzymatically inactive phospholipase d of corynebacterium pseudotuberculosis |
03/23/1993 | US5196525 DNA construct for enhancing the efficiency of transcription |
03/23/1993 | US5196524 Fusion reporter gene for bacterial luciferase |
03/23/1993 | US5196523 Control of gene expression by glucose, calcium and temperature |
03/23/1993 | US5196516 Pseudorabies virus vaccine |
03/23/1993 | US5196511 Peptides and antibodies that inhibit integrin-ligand binding |
03/23/1993 | US5196352 New FK-506 cytosolic binding protein |
03/23/1993 | US5196342 Bacillus thuringiensis P-2 toxin gene |
03/23/1993 | US5196338 Recombinant vectors for Haemophilus influenzae peptides and proteins |
03/23/1993 | US5196337 Human monoclonal antibody, and its production and use |
03/23/1993 | US5196335 Genetic engineering |
03/23/1993 | US5196332 Cloning the Hae II restriction and modification genes |
03/23/1993 | US5196331 Cloning the MspI restriction and modification genes |
03/23/1993 | US5196330 Type ii restriction endonuclease, pme i, obtainable from pseudomonas mendocina and a process for producing the same |
03/23/1993 | US5196329 780 T-DNA gene transcription activator |
03/23/1993 | US5196328 Modified cloning vectors for restriction mapping, their preparation and use |
03/23/1993 | US5196324 Monoclonal antibodies reactive with a human atheroma associated antigen |
03/23/1993 | US5196322 Genetic engineering, anticoagulants |
03/23/1993 | US5196321 Methods for in vitro cleavage of ubiquitin fusion proteins |
03/23/1993 | US5196320 Method of producing engineered binding proteins |
03/23/1993 | US5196319 Primary biliary cirrhosis autoantigen |
03/23/1993 | US5196318 Precisely regulated expression of deleterious genes |
03/23/1993 | US5196317 Overexpression of proteins in recombinant host cells |
03/23/1993 | US5196316 Enzyme and dna coding therefor |
03/23/1993 | US5196308 Methods for identifying the DQw3.2 allele associated with increased risk of insulin-dependent diabetes mellitus |
03/23/1993 | US5196307 Cloned human centromere autoantigen |
03/23/1993 | US5196305 Diagnostic and amplification methods using primers having thymine at 3' end to overcome primer-target mismatch at the 3' end |
03/23/1993 | US5196304 Serine proteinase inhibitor gene from the insect Manduca sexta |
03/23/1993 | US5196194 Vaccines containing Hepatitis B S-protein |
03/23/1993 | CA1314831C Extraction of human interleukin-4 from bacteria |
03/23/1993 | CA1314830C Bar1 secretion signal |
03/23/1993 | CA1314811C Methods for identifying alleles associated with increased risk of diabetes |
03/23/1993 | CA1314810C Heterologous system for the detection of chemically-labeled dna and other biological materials providing a receptor or target moiety thereon |
03/21/1993 | CA2078358A1 Multivalent hepatitis b virus vaccine |
03/19/1993 | CA2078525A1 Expression vector and silkworm larvae transformant containing the same |
03/19/1993 | CA2078384A1 Chimaeric interleukin 5-receptor/immunoglobulin polypeptides |
03/18/1993 | WO1993005180A1 Formation of triple helix complexes of double stranded dna using nucleoside oligomers which comprise purine base analogs |
03/18/1993 | WO1993005172A1 Morphogenic protein screening method |
03/18/1993 | WO1993005169A1 Hybrid cytokines |
03/18/1993 | WO1993005168A1 Dna sequences encoding gelonin polypeptide |
03/18/1993 | WO1993005166A1 Methods for the selection, separation and fusion of cells |
03/18/1993 | WO1993005165A1 Yeast artificial chromosomes and their use in the control of gene expression |
03/18/1993 | WO1993005164A1 Callus-specific promoters |
03/18/1993 | WO1993005163A1 Method for the selection of genetically transformed cells and compounds for use in the method |
03/18/1993 | WO1993005162A1 Method for delivering nucleic acids into cells |
03/18/1993 | WO1993005161A1 Lactobacilli having genetically modified bile salt hydrolytic activity, production and use thereof |
03/18/1993 | WO1993005160A1 Modification of lignin synthesis in plants |
03/18/1993 | WO1993005159A1 Modification of lignin synthesis in plants |
03/18/1993 | WO1993005158A1 Novel bioprocess for preparing 7-adca |
03/18/1993 | WO1993005157A1 Ribosomal structure derived from the genomic rna structure of the delta hepatitus virus |
03/18/1993 | WO1993005156A1 Streptolysin o derivatives |
03/18/1993 | WO1993005155A1 Streptolysin o variants |
03/18/1993 | WO1993005154A1 Ammonia production by a recombinant nitrogen fixing bacteria |
03/18/1993 | WO1993005153A1 Biocidal proteins |
03/18/1993 | WO1993005151A1 Cloned human cenp-c antigen |
03/18/1993 | WO1993005150A1 Collagen-induced platelet aggregation inhibitor |
03/18/1993 | WO1993005149A1 Subtractive hybridization cloning for probes for gene isolation and mapping |
03/18/1993 | WO1993005148A1 Mutated growth factor receptor as medicament and its use for treating cancer |
03/18/1993 | WO1993005147A1 Defective interfering hiv particles with chimeric cd4-env |
03/18/1993 | WO1993005146A1 Molecules with antibody combining sites that induce asymmetry |
03/18/1993 | WO1993005072A1 Disease associated human autoantibodies specific for human thyroid peroxidase |
03/18/1993 | WO1993005071A1 INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS |
03/18/1993 | WO1993005070A1 Peptide inhibitors of inflammation mediated by selectins |
03/18/1993 | WO1993005062A1 SYNTHETIC tRNAs |
03/18/1993 | WO1993005061A1 Cloning and characterization of a cardiac adenylyl cyclase |
03/18/1993 | WO1993005060A1 Functionalized carrier materials for the simultaneous synthesis and direct labeling of oligonucleotides as primers for the matrix-dependant, enzymatic synthesis of nucleic acids |
03/18/1993 | WO1993005056A1 A helix-loop-helix zipper protein that forms a sequence-specific dna-binding complex with myc and mad |
03/18/1993 | WO1993004710A2 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone |
03/18/1993 | WO1993004701A1 Targeted delivery of poly- or oligonucleotides to cells |
03/18/1993 | WO1993004695A1 T cell receptor-based therapy for rheumatoid arthritis |